Комплаентность реципиентов печени

DOI: https://doi.org/10.29296/25877305-2019-05-02
Скачать статью в PDF
Номер журнала: 
5
Год издания: 
2019

Е. Космачева(1, 2), доктор медицинских наук, профессор, А. Бабич(1, 2) 1-Научно-исследовательский институт – Краевая клиническая больница №1 им. проф. С.В. Очаповского, Краснодар 2-Кубанский государственный медицинский университет, Краснодар Е-mail: anna-babich1@yandex.ru

Приведен обзор зарубежной литературы, дающей представление о комплаентности реципиентов печени, ее уровне, методах изучения. Данные разных трансплантационных центров о комплаентности реципиентов печени противоречивы (от 3 до 99%). Низкая приверженность реципиентов печени выполнению врачебных рекомендаций коррелирует с существенным увеличением показателей позднего острого отторжения, потери трансплантата и смерти. Рассматриваются возможные причины противоречивости данных о комплаентности таких пациентов.
Ключевые слова: 
гепатология
комплаентность
трансплантация печени
отторжение трансплантата
иммуносупрессия
Для цитирования
Космачева Е., Бабич А. Комплаентность реципиентов печени . Врач, 2019; (5): 11-14 https://doi.org/10.29296/25877305-2019-05-02

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

Список литературы: 
  1. Kim W., Lake J., Smith J. et al. OPTN/SRTR 2015 Annual Data Report: liver // Am. J. Transplant. – 2017; 17: 174–251. DOI: 10.1111/ajt.14126.
  2. World Health Organization. Secondary prevention of non-communicable disease in low and middle-income countries through community-based and health service interventions. Wellcome Trust meeting report. 1–3 Aug 2001. WHO, 2002.
  3. Национальные рекомендации Российского научного медицинского общества терапевтов по количественной оценке приверженности лечению / М., 2017; 24 [Nacional`ny`e rekomendacii Rossijskogo nauchnogo medicinskogo obshhestva terapevtov po kolichestvennoj ocenke priverzhennosti k lecheniyu / М., 2017; 24 (in Russ.)].
  4. Kardas P. Patient compliance with antibiotic treatment for respiratory tract infections // Antimicrob. Chemother. – 2002; 49: 897–903.
  5. Insull W. The problem of compliance to cholesterol altering therapy // Int. Med. – 1997; 241: 317–25.
  6. Schweizer R., Rovelli M., Palmeri D. еt al. Noncompliance in organ transplant recipients // Transplantation. – 1990; 49: 374–7.
  7. Berlakovich G., Langer F., Freundorfer E. et al. General compliance after liver transplantation for alcoholic cirrhosis // Transpl. Int. – 2000; 13: 129–35.
  8. Stilley C., DiMartini A., de Vera M. et al. Individual and environmental correlates and predictors of early adherence and outcomes after liver transplantation // Prog. Transplant. – 2010; 20: 58–66.
  9. O’Carroll R., McGregor L., Swanson V. et al. Adherence to medication after liver transplantation in Scotland: a pilot study // Liver Transpl. – 2006; 12: 1862–8. DOI: 10.1002/lt.20828.
  10. Drent G., Haagsma E., Geest S. et al. Prevalence of prednisolone (non)compliance in adult liver transplant recipients // Transpl. Int. – 2005; 18: 960–6.
  11. Национальные клинические рекомендации: трансплантация печени. Пересм. 2016. [Nacional`ny`e klinicheskie rekomendacii: transplantaciya pecheni. Peresmotr: 2016 (in Russ.)].
  12. Farkas S. Calcineurin inhibitor minimization protocols in liver transplantat ion // Transpl. Int. – 2009; 22: 49–60.
  13. Naesens M., Kuypers D., Sarwal M. Calcineurin inhibitor nephrotoxicity // Clin. L. Am. Soc. Nephrol. – 2009; 4: 481–508.
  14. Siddharth S., Watt K. Long-term medical management of the liver transplant recipient: what the primary care physician needs to know // Mayo Clinic Rev. – 2012; 87: 779–90.
  15. Shemesh E., Shneider B., Savitzky J. et al. Medication adherence in pediatric and adolescent liver transplant recipients // Pediatrics. – 2004; 113: 825–32.
  16. Fredericks E., Magee J., Opipari-Arrigan L. et al. Adherence and health-related quality of life in adolescent liver transplant recipients // Pediatr. Transplant. – 2008; 12: 289–99. DOI: 10.1111/j.1399-3046.2008.00901.x.
  17. Annunziato R., Emre S., Shneider B. et al. Adherence and medical outcomes in pediatric liver transplant recipients who transition to adult services // Pediatr. Transplant. – 2007; 11: 608–14. DOI: 10.1111/j.1399-3046.2007.00689.x
  18. Avitzur Y., De Luca E., Cantos M. et al. Health status ten years after pediatric liver transplantation—looking beyond the graft // Transplantation. – 2004; 78: 566–73.
  19. Berquist R., Berquist W., Esquivel C. et al. Adolescent non-adherence: prevalence and consequences in liver transplant recipients // Pediatr. Transplant. – 2006; 10: 304–10. DOI: 10.1111/j.1399-3046.2005.00451.x.
  20. Berquist R., Berquist W., Esquivel C. et al. Non-adherence to post-transplant care: prevalence, risk factors and outcomes in adolescent liver transplant recipients // Pediatr. Transplant. – 2008; 12: 194–200. DOI: 10.1111/j.1399-3046.2007.00809.x.
  21. Bueno J., Medina A., Ortega J. et al. Liver transplantation in childhood with more than 10 years of follow-up: analysis of a single-center experience // Transplant. Proc. – 2007; 39: 2288–9. DOI: 10.1016/j.transproceed.2007.06.052.
  22. Falkenstein K., Flynn L., Kirkpatrick B. et al. Non-compliance in children post-liver transplant. Who are the culprits? // Pediatr. Transplant. – 2004; 8: 233–6. DOI: 10.1111/j.1399-3046.2004.00136.x.
  23. Fredericks E., Lopez M., Magee J. et al. Psychological functioning, nonadherence and health outcomes after pediatric liver transplantation // Am. J. Transplant. – 2007; 7: 1974–83. DOI: 10.1111/j.1600-6143.2007.01878.x.
  24. Rumbo C., Shneider B., Emre S. Utility of azathioprine metabolite measurements in post-transplant recurrent autoimmune and immune-mediated hepatitis // Pediatr. Transplant. – 2004; 8: 571–5.
  25. Shemesh E., Annunziato R., Shneider B. et al. Improving adherence to medications in pediatric liver transplant recipients // Pediatr. Transplant. – 2008; 12: 316–23.
  26. Venkat V., Nick T., Wang Y. et al. An objective measure to identify pediatric liver transplant recipients at risk for late allograft rejection related to non-adherence // Pediatr. Transplant. – 2008; 12: 67–72. DOI: 10.1111/j.1399-3046.2007.00794.x.
  27. Darcy A., Samyn M. Looking after young people with liver conditions: understanding chronic illness management in the context of adolescent development // Clin. Liver Dis. – 2017; 9: 103–6.
  28. Mor E., Gonwa T., Husberg B. et al. Late-onset acute rejection in orthotopic liver transplantation-associated risk factors and outcome // Transplantation. – 1992; 54: 821–4.
  29. Drent G., De Geest S., Dobbels F. et al. Symptom experience, nonadherence and quality of life in adult liver transplant recipients // Neth. J. Med. – 2009; 67: 161–8.
  30. Quittner A., Modi A., Lemanek K. et al. Evidence-based assessment of adherence to medical treatments in pediatric psychology // J. Pediatr. Psychol. – 2008; 33: 916–36. DOI: 10.1093/jpepsy/jsm064.
  31. Asavakarn S., Sirivatanauksorn Y., Promraj R. et al. Systematic pharmaceutical educational approach to enhance drug adherence in liver transplant recipients // Transplant. Proc. – 2016; 48: 1202–7. DOI: 10.1016/j.transproceed.2015.12.100.
  32. Miloh T., Annunziato R., Arnon R. et al. Improved adherence and outcomes for pediatric liver transplant recipients by using text messaging // Pediatrics. – 2009; 124: 844–50. DOI: 10.1542/peds.2009-0415.
  33. Zanetti-Yabur A., Rizzo A., Hayde N. et al. Exploring the usage of a mobile phone application in transplanted patients to encourage medication compliance and education // Am. J. Surg. – 2017; 214: 743–7. DOI: 10.1016/j.amjsurg.2017.01.026.